Clinical TrialsSearch results
Number of results: 270
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma:
the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Other
- Multicenter Phase II Study of Combination Epitope Peptides with mFOLFOX6 in Advanced/metastatic Colorectal Cancer
- Metastatic chemo naive colorectal cancer
- YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology
- 2009-05-01
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer
- previously untreated elderly non-small cell lung cancer
- West Japan Oncology Group
- 2005-08-22
Other
- A combination phase I/II study of topotecan with carboplatin for relapsed small cell lung cancer
- relapsed small cell lung cancer
- West Japan Oncology Group
- 2005-09-07
Other
- A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimen
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-13
Other
- A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer
- small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer
- Thymic cancer
- West Japan Oncology Group
- 2008-09-08